These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2867603)

  • 21. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [International symposium on piribedil].
    ZFA (Stuttgart); 1979 Jan; 55(3):172-4. PubMed ID: 33499
    [No Abstract]   [Full Text] [Related]  

  • 23. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Polygraphic, clinical and therapeutic markers of dopamine-dependent depressions].
    Mouret J; Lemoine P; Minuit MP
    C R Acad Sci III; 1987; 305(8):301-6. PubMed ID: 3115502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The treatment of diabetic arteritis of the lower limbs by Trivastal].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):326-31. PubMed ID: 4679620
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic trial of Trivastal (EU 4200) in diabetic arteritis].
    Leng-Lévy J; Aubertin J; Leng B; Marion J; Magendie P; Warin JF
    Bord Med; 1970 Feb; 3(2):533-8. PubMed ID: 5425880
    [No Abstract]   [Full Text] [Related]  

  • 27. [Trivastal in diabetic vascular disorders].
    Guinet P; Poncet J
    Rev Lyon Med; 1969 Oct; 18(16):625-36. PubMed ID: 5400625
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of Trivastal in otorhinolaryngology].
    Haguenauer JP; Vautel JM
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Feb; 21(2):173-9. PubMed ID: 4261611
    [No Abstract]   [Full Text] [Related]  

  • 29. DA agonists -- non-ergot derivatives: piribedil: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S90-2. PubMed ID: 12211147
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: Effects of piribedil (ET 495)--a dopaminergic receptor stimulating agent in Parkinson's disease.
    Lieberman A; Le Brun Y; Zolfaghari M
    Psychopharmacol Bull; 1974 Jul; 10(3):42-3. PubMed ID: 4419369
    [No Abstract]   [Full Text] [Related]  

  • 31. Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions.
    de Azevedo AA; Langguth B; de Oliveira PM; Rodrigues Figueiredo R
    Otol Neurotol; 2009 Aug; 30(5):676-80. PubMed ID: 19574947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
    Rascol O; Dubois B; Caldas AC; Senn S; Del Signore S; Lees A;
    Mov Disord; 2006 Dec; 21(12):2110-5. PubMed ID: 17013922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up].
    Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC
    Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
    Turle-Lorenzo N; Maurin B; Puma C; Chezaubernard C; Morain P; Baunez C; Nieoullon A; Amalric M
    J Pharmacol Exp Ther; 2006 Nov; 319(2):914-23. PubMed ID: 16920993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
    Smith LA; Tel BC; Jackson MJ; Hansard MJ; Braceras R; Bonhomme C; Chezaubernard C; Del Signore S; Rose S; Jenner P
    Mov Disord; 2002 Sep; 17(5):887-901. PubMed ID: 12360537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting.
    Hastak SM
    J Indian Med Assoc; 2003 Aug; 101(8):500-1. PubMed ID: 15071809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.
    Simon N; Micallef J; Reynier JC; Lesourd M; Witjas T; Alicherif A; Azulay JP; Blin O
    Mov Disord; 2005 Jul; 20(7):803-9. PubMed ID: 15726579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Edematous maculopathies and piribedil].
    Jayle GE; Metge P
    Annee Ther Clin Ophtalmol; 1972; 23():363-98. PubMed ID: 4680289
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of piribedil (ET-495) on plasma norepinephrine: relationship to antidepressant response.
    Reus VI; Lake CR; Post RM
    Commun Psychopharmacol; 1980; 4(3):207-13. PubMed ID: 7226752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.